Why the study?
Does vasopressor therapy terminate paroxysmal supraventricular and ventricular tachycardia?
Does vasopressor therapy terminate paroxysmal supraventricular and ventricular tachycardia?
Vasopressor therapy has been recognized to terminate paroxysmal supraventricular and ventricular tachycardias, with recent insights into the underlying coronary hemodynamic mechanisms.
Answers are grounded in this paper and cite their sources.
Vasopressor termination of paroxysmal tachycardias remains unproven; leaves open the need for randomized trials before any practice consideration.
IN the last decade many investigators have demonstrated that the administration of vasopressor drugs may terminate paroxysmal supraventricular and ventricular tachycardia.1 2 3 4 5 6 7 8 9 10 11 However, it is only recently that the physiologic mechanism of this effect has become clear as a result of the experimental demonstration of the hemodynamic behavior of the coronary circulation during the arrhythmias.12 13 14 Clinicians have long recognized that anginal pain occurs during rapid tachycardias or frequent premature systoles. Furthermore, electrocardiographic and morphologic myocardial changes typical of coronary insufficiency often follow a prolonged paroxysm of tachycardia, particularly if coronary-artery narrowing exists. Rapid supraventricular and ventricular tachycardias may cause a marked . . .
No takes yet. Share an insight, caveat, or question.
Gold et al. (1959) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: